Erica Golemis

Citée par

	Toutes	Depuis 2020
Citations	22679	5916
indice h	81	38
indice i10	194	119

1300

650

325

975

199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202558 59 119 220 308 440 556 558 567 634 606 644 608 589 563 538 591 626 674 653 792 765 951 892 752 827 887 977 1173 1277 1163 1111 1022 166

Accès public

Tout afficher

128 articles

4 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Ilya SerebriiskiiFox Chase Cancer CenterAdresse e-mail validée de fccc.edu
Anna NikonovaPostdoctoral associate at Fox Chase Cancer CenterAdresse e-mail validée de fccc.edu
Alexander DenekaFox Chase Cancer CenterAdresse e-mail validée de fccc.edu
Roger BrentProfessor of Basic Sciences, FHCRCAdresse e-mail validée de fhcrc.org
Tim N Beck, M.D., Ph.DDignity Health Medical Group - BakersfieldAdresse e-mail validée de commonspirit.org
Roland DunbrackFox Chase Cancer CenterAdresse e-mail validée de fccc.edu
Sanjeevani Arora, PhDFox Chase Cancer CenterAdresse e-mail validée de fccc.edu
Geraldine M O'NeillThe Children's Hospital at WestmeadAdresse e-mail validée de health.nsw.gov.au
Tamina Seeger-NukpezahUniversity of CologneAdresse e-mail validée de uk-koeln.de
Vlad KorobeynikovColumbia UniversityAdresse e-mail validée de cumc.columbia.edu
Anna A KiselevaUniversity of PennsylvaniaAdresse e-mail validée de pennmedicine.upenn.edu
Mahendra K. SinghResearch Assistant Professor, Department of Surgery, University of MiamiAdresse e-mail validée de miami.edu
Joy L. LittleNorth Carolina State UniversityAdresse e-mail validée de ncsu.edu
Vladimir Ratushny, M.D., Ph.D.Drexel University College of MedicineAdresse e-mail validée de drexel.edu
Jonathan ChernoffFox Chase Cancer CenterAdresse e-mail validée de fccc.edu
Anne Astier, PhDINSERM - CNRS - INFINITY ToulouseAdresse e-mail validée de inserm.fr
Hava AvrahamResearch Associate Professor, Center of Drug Discovery, Northeastern University, BostonAdresse e-mail validée de bidmc.harvard.edu
Russell L. Finley Jr.Professor of Molecular Medicine and Genetics, Wayne State UniversityAdresse e-mail validée de wayne.edu
Thomas BenzingProfessor of Medicine, University of CologneAdresse e-mail validée de uk-koeln.de
Lutz WeberMolGenie, OntoChem, Alphaptose, NexusPharma, Morphochem, HoffmannLa Roche, Uni Leipzig, BME BudapestAdresse e-mail validée de molgenie.com

Suivre

Erica Golemis

Professor, Assoc. Director for System Integration, Fox Chase Cancer Center, and Chair, LKSOM

Adresse e-mail validée de fccc.edu - Page d'accueil

Cancer Targeted therapy Signal Transduction Polycystic Kidney Disease


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2 J Gyuris, E Golemis, H Chertkov, R Brent Cell 75 (4), 791-803, 1993	1984	1993
HEF1-dependent Aurora A activation induces disassembly of the primary cilium EN Pugacheva, SA Jablonski, TR Hartman, EP Henske, EA Golemis Cell 129 (7), 1351-1363, 2007	998	2007
Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. T Sato, M Hanada, S Bodrug, S Irie, N Iwama, LH Boise, CB Thompson, ... Proceedings of the National Academy of Sciences 91 (20), 9238-9242, 1994	828	1994
Correlation of two-hybrid affinity data with in vitro measurements J Estojak, R Brent, EA Golemis Molecular and cellular biology, 1995	717	1995
Aurora A kinase (AURKA) in normal and pathological cell division AS Nikonova, I Astsaturov, IG Serebriiskii, RL Dunbrack, EA Golemis Cellular and Molecular Life Sciences 70, 661-687, 2013	550	2013
Defects in DNA repair genes predict response to neoadjuvant cisplatin-based chemotherapy in muscle-invasive bladder cancer ER Plimack, RL Dunbrack, TA Brennan, MD Andrake, Y Zhou, ... European urology 68 (6), 959-967, 2015	500	2015
The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis GH Xiao, F Shoarinejad, F Jin, EA Golemis, RS Yeung Journal of Biological Chemistry 272 (10), 6097-6100, 1997	434	1997
Interaction trap/two‐hybrid system to identify interacting proteins EA Golemis, I Serebriiskii, RL Finley Jr, MG Kolonin, J Gyuris, R Brent Current protocols in cell biology 8 (1), 17.3. 1-17.3. 42, 2000	429	2000
Integrin signalling: a new Cas (t) of characters enters the stage GM O’Neill, SJ Fashena, EA Golemis Trends in cell biology 10 (3), 111-119, 2000	372	2000
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 A Bellacosa, L Cicchillitti, F Schepis, A Riccio, AT Yeung, Y Matsumoto, ... Proceedings of the National Academy of Sciences 96 (7), 3969-3974, 1999	348	1999
Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae SF Law, J Estojak, B Wang, T Mysliwiec, G Kruh, EA Golemis Molecular and cellular biology, 1996	292	1996
Primary cilia and the cell cycle OV Plotnikova, EN Pugacheva, EA Golemis Methods in cell biology 94, 137-160, 2009	289	2009
The focal adhesion scaffolding protein HEF1 regulates activation of the Aurora-A and Nek2 kinases at the centrosome EN Pugacheva, EA Golemis Nature cell biology 7 (10), 937-946, 2005	277	2005
Musashi RNA-binding proteins as cancer drivers and novel therapeutic targets AE Kudinov, J Karanicolas, EA Golemis, Y Boumber Clinical Cancer Research 23 (9), 2143-2153, 2017	271	2017
Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22 I Serebriiskii, J Estojak, G Sonoda, JR Testa, EA Golemis Oncogene 15 (9), 1043-1049, 1997	264	1997
Identification of a chromosome 3p14. 3-21.1 gene, APPL, encoding an adaptor molecule that interacts with the oncoprotein-serine/threonine kinase AKT2 Y Mitsuuchi, SW Johnson, G Sonoda, S Tanno, EA Golemis, JR Testa Oncogene 18 (35), 4891-4898, 1999	257	1999
Fused protein domains inhibit DNA binding by LexA EA Golemis, R Brent Molecular and cellular biology 12 (7), 3006-3014, 1992	248	1992
HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells M Natarajan, JE Stewart, EA Golemis, EN Pugacheva, K Alexandropoulos, ... Oncogene 25 (12), 1721-1732, 2006	242	2006
AH/PH domain-mediated interaction between Akt molecules and its potential role in Akt regulation K Datta, TF Franke, TO Chan, A Makris, SI Yang, DR Kaplan, DK Morrison, ... Molecular and cellular biology 15 (4), 2304-2310, 1995	232	1995
CAS proteins in normal and pathological cell growth control N Tikhmyanova, JL Little, EA Golemis Cellular and molecular life sciences 67, 1025-1048, 2010	229	2010

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs